 |
Coagulation factor IX |
|---|---|
| Trade Name | Mononine |
| Orphan Indication | Replacement treatment and prophylaxis of the hemorrhagic complications of hemophilia B |
| USA Market Approval | USA |
| USA Designation Date | 1989-06-27 00:00:00 |
| Sponsor | Armour Pharmaceutical Company;500 Arcola Road, P.O. Box 1200;Collegeville, Pennsylvania, 19426 |
